Archives of Pediatric Infectious Diseases

Published by: Kowsar

Normal Salivary Cortisol and NK Cell Function in Adolescents With Chronic Fatigue Syndrome Following Infectious Mononucleosis

Ben Z Katz 1 , 2 , * , Donald Zimmerman 1 , 2 , Maurice RG Gorman 2 , 3 , 4 , Cynthia J Mears 1 , 2 , Yukiko Shiraishi 5 and Renee Taylor 5
Authors Information
1 Department of Pediatrics, School of Medicine, Northwestern University, Chicago, USA
2 Feinberg and the Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, USA
3 Department of Pathology, School of Medicine, Northwestern University, Chicago, USA
4 Department of Occupational Health, Northwestern University, Chicago, USA
5 College of Applied Sciences, University of Illinois, Chicago, USA
Article information
  • Archives of Pediatric Infectious Diseases: April 01, 2014, 2 (2); 211-216
  • Published Online: April 20, 2014
  • Article Type: Research Article
  • Received: June 21, 2013
  • Revised: August 16, 2013
  • Accepted: October 19, 2013
  • DOI: 10.5812/pedinfect.13107

To Cite: Katz B Z, Zimmerman D, Gorman M R, Mears C J, Shiraishi Y, et al. Normal Salivary Cortisol and NK Cell Function in Adolescents With Chronic Fatigue Syndrome Following Infectious Mononucleosis, Arch Pediatr Infect Dis. 2014 ; 2(2):211-216. doi: 10.5812/pedinfect.13107.

Copyright © 2014, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994; 121(12): 953-9[PubMed]
  • 2. Katz BZ, Jason LA. Chronic fatigue syndrome following infections in adolescents. Curr Opin Pediatr. 2013; 25(1): 95-102[DOI][PubMed]
  • 3. Richards J, Turk J, White S. Children and adolescents with Chronic Fatigue Syndrome in non-specialist settings: beliefs, functional impairment and psychiatric disturbance. Eur Child Adolesc Psychiatry. 2005; 14(6): 310-8[DOI][PubMed]
  • 4. ter Wolbeek M, van Doornen LJ, Kavelaars A, Heijnen CJ. Severe fatigue in adolescents: a common phenomenon? Pediatrics. 2006; 117(6)-86[DOI][PubMed]
  • 5. White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Kangro HO, et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry. 1998; 173: 475-81[PubMed]
  • 6. Buchwald DS, Rea TD, Katon WJ, Russo JE, Ashley RL. Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am J Med. 2000; 109(7): 531-7[PubMed]
  • 7. Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006; 333(7568): 575[DOI][PubMed]
  • 8. Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics. 2009; 124(1): 189-93[DOI][PubMed]
  • 9. Katz BZ, Boas S, Shiraishi Y, Mears CJ, Taylor R. Exercise tolerance testing in a prospective cohort of adolescents with chronic fatigue syndrome and recovered controls following infectious mononucleosis. J Pediatr. 2010; 157(3): 468-72[DOI][PubMed]
  • 10. Katz BZ, Stewart JM, Shiraishi Y, Mears CJ, Taylor R. Orthostatic tolerance testing in a prospective cohort of adolescents with chronic fatigue syndrome and recovered controls following infectious mononucleosis. Clin Pediatr (Phila). 2012; 51(9): 835-9[DOI][PubMed]
  • 11. Huang Y, Katz BZ, Mears C, Kielhofner GW, Taylor R. Postinfectious fatigue in adolescents and physical activity. Arch Pediatr Adolesc Med. 2010; 164(9): 803-9[DOI][PubMed]
  • 12. Katz BZ, Stewart JM, Shiraishi Y, Mears CJ, Taylor R. Autonomic symptoms at baseline and following infectious mononucleosis in a prospective cohort of adolescents. Arch Pediatr Adolesc Med. 2011; 165(8): 765-6[DOI][PubMed]
  • 13. Broderick G, Katz BZ, Fernandes H, Fletcher MA, Klimas N, Smith FA, et al. Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue. J Transl Med. 2012; 10: 191[DOI][PubMed]
  • 14. Bansal AS, Bradley AS, Bishop KN, Kiani-Alikhan S, Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun. 2012; 26(1): 24-31[DOI][PubMed]
  • 15. Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. 1990; 28(6): 1403-10[PubMed]
  • 16. Fletcher MA, Zeng XR, Maher K, Levis S, Hurwitz B, Antoni M, et al. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PLoS One. 2010; 5(5)
  • 17. Siegel SD, Antoni MH, Fletcher MA, Maher K, Segota MC, Klimas N. Impaired natural immunity, cognitive dysfunction, and physical symptoms in patients with chronic fatigue syndrome: preliminary evidence for a subgroup? J Psychosom Res. 2006; 60(6): 559-66[DOI][PubMed]
  • 18. Tirelli V, Pinto A, Marotta G, Crovato M, Quaia M, De Paoli P, et al. Clinical and immunologic study of 205 patients with chronic fatigue syndrome: a case series from Italy. Arch Intern Med. 1993; 153(1): 116-7[PubMed]
  • 19. Barker E, Fujimura SF, Fadem MB, Landay AL, Levy JA. Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis. 1994; 18 Suppl 1-41[PubMed]
  • 20. Ojo-Amaize EA, Conley EJ, Peter JB. Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome. Clin Infect Dis. 1994; 18 Suppl 1-9[PubMed]
  • 21. Masuda A, Nozoe SI, Matsuyama T, Tanaka H. Psychobehavioral and immunological characteristics of adult people with chronic fatigue and patients with chronic fatigue syndrome. Psychosom Med. 1994; 56(6): 512-8[PubMed]
  • 22. Levine PH, Whiteside TL, Friberg D, Bryant J, Colclough G, Herberman RB. Dysfunction of natural killer activity in a family with chronic fatigue syndrome. Clin Immunol Immunopathol. 1998; 88(1): 96-104[PubMed]
  • 23. Brenu EW, Staines DR, Baskurt OK, Ashton KJ, Ramos SB, Christy RM, et al. Immune and hemorheological changes in chronic fatigue syndrome. J Transl Med. 2010; 8: 1[DOI][PubMed]
  • 24. Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, et al. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2012; 10: 88[DOI][PubMed]
  • 25. Rasmussen AK, Nielsen H, Andersen V, Barington T, Bendtzen K, Hansen MB, et al. Chronic fatigue syndrome--a controlled cross sectional study. J Rheumatol. 1994; 21(8): 1527-31[PubMed]
  • 26. Mawle AC, Nisenbaum R, Dobbins JG, Gary HE, Jr, Stewart JA, Reyes M, et al. Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis. 1997; 175(1): 136-41[PubMed]
  • 27. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988; 108(3): 387-9[PubMed]
  • 28. Roberts AD, Wessely S, Chalder T, Papadopoulos A, Cleare AJ. Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatry. 2004; 184: 136-41[PubMed]
  • 29. Wood B, Wessely S, Papadopoulos A, Poon L, Checkley S. Salivary cortisol profiles in chronic fatigue syndrome. Neuropsychobiology. 1998; 37(1): 1-4[PubMed]
  • 30. Rahman K, Burton A, Galbraith S, Lloyd A, Vollmer-Conna U. Sleep-wake behavior in chronic fatigue syndrome. Sleep. 2011; 34(5): 671-8[PubMed]
  • 31. Candy B, Chalder T, Cleare AJ, Peakman A, Skowera A, Wessely S, et al. Predictors of fatigue following the onset of infectious mononucleosis. Psychol Med. 2003; 33(5): 847-55[PubMed]
  • 32. Strickland P, Morriss R, Wearden A, Deakin B. A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. J Affect Disord. 1998; 47(1-3): 191-4[PubMed]
  • 33. Jerjes WK, Cleare AJ, Wessely S, Wood PJ, Taylor NF. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. J Affect Disord. 2005; 87(2-3): 299-304[DOI][PubMed]
  • 34. Nater UM, Maloney E, Boneva RS, Gurbaxani BM, Lin JM, Jones JF, et al. Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls. J Clin Endocrinol Metab. 2008; 93(3): 703-9[DOI][PubMed]
  • 35. Nater UM, Youngblood LS, Jones JF, Unger ER, Miller AH, Reeves WC, et al. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med. 2008; 70(3): 298-305[DOI][PubMed]
  • 36. Jonsson BA, Malmberg B, Amilon A, Helene Garde A, Orbaek P. Determination of cortisol in human saliva using liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 784(1): 63-8[PubMed]
  • 37. Hatam L, Schuval S, Bonagura VR. Flow cytometric analysis of natural killer cell function as a clinical assay. Cytometry. 1994; 16(1): 59-68[DOI][PubMed]
  • 38. Whiteside TL. Manual of Clinical Laboratory Immunology 6th edition. 2002; : 296-300
  • 39. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989; 47: 187-376[PubMed]
  • 40. McKenzie R, O'Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA. 1998; 280(12): 1061-6[PubMed]
  • 41. Peterson PK, Pheley A, Schroeppel J, Schenck C, Marshall P, Kind A, et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch Intern Med. 1998; 158(8): 908-14[PubMed]
  • 42. Cleare AJ, Heap E, Malhi GS, Wessely S, O'Keane V, Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet. 1999; 353(9151): 455-8[DOI][PubMed]
  • 43. Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, et al. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab. 2001; 86(8): 3545-54[PubMed]
  • 44. Blockmans D, Persoons P, Van Houdenhove B, Lejeune M, Bobbaers H. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study. Am J Med. 2003; 114(9): 736-41[PubMed]
  • 45. Cleare AJ, O'Keane V, Miell JP. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. Psychoneuroendocrinology. 2004; 29(6): 724-32[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments